NCM Capital Management Group’s Gilead Sciences GILD Stock Holding History

NCM Capital Management Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$126K	Hold	1,597	–	–	1.53%	26
2016 Q2	$133K	Sell	1,597 -50	-3%	-$4.44K	1.62%	24
2016 Q1	$151K	Sell	1,647 -50	-3%	-$4.51K	1.84%	18
2015 Q4	$172K	Hold	1,697	–	–	2.02%	16
2015 Q3	$167K	Hold	1,697	–	–	2.07%	16
2015 Q2	$199K	Hold	1,697	–	–	2.24%	10
2015 Q1	$166K	Buy	1,697 +254	+18%	+$25.8K	1.89%	17
2014 Q4	$136K	Buy	1,443 +493	+52%	+$51K	1.53%	27
2014 Q3	$101K	Sell	950 -150	-14%	-$14.7K	1.19%	36
2014 Q2	$91K	Sell	1,100 -1,230	-53%	-$95.7K	1.06%	41
2014 Q1	$165K	Sell	2,330 -30,620	-93%	-$2.4M	1.3%	27
2013 Q4	$2.48M	Sell	32,950 -21,800	-40%	-$1.52M	1.63%	18
2013 Q3	$3.44M	Buy	54,750 +9,050	+20%	+$541K	2.48%	5
2013 Q2	$2.34M	Buy	+45,700	New	+$2.38M	1.8%	20

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NCM Capital Management Group's GILD Position: Q3 2016 in Review

NCM Capital Management Group held its Gilead Sciences (GILD) position steady in Q3 2016 at 1,597 shares worth $126K. The position accounts for 1.53% of the portfolio, ranked #26.

NCM Capital Management Group first reported a position in GILD in Q2 2013 and has held it in 14 quarters since. The position peaked at $3.44M in Q3 2013. 1,557 funds tracked by Wall St. Rank hold GILD as of Q3 2016.

NCM Capital Management Group held 1,597 shares of Gilead Sciences worth $126K as of Q3 2016.
NCM Capital Management Group left its Gilead Sciences share count unchanged in Q3 2016.
Gilead Sciences made up 1.53% of NCM Capital Management Group's portfolio in Q3 2016, its #26 holding.
NCM Capital Management Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 14 quarters since.
NCM Capital Management Group's Gilead Sciences position peaked at $3.44M in Q3 2013.
1,557 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2016.

Based on NCM Capital Management Group's 13F filing for Q3 2016, filed 7 Nov 2016.